In June 2020, the U.S. Food and Drug Administration (FDA) issued a warning letter to a drug manufacturing facility, citing a number of infractions, including these common data integrity issues: 1 Missing raw data files associated with recovered solvent testing were observed in folders on the local hard drive of…